Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

BACKGROUND: Pathological complete remission (pCR) of estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer is rarely achieved after neoadjuvant chemotherapy (NAC). In addition, the prognostic value of pCR for this breast cancer subtype is limited. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Loo, Claudette E., Rigter, Lisanne S., Pengel, Kenneth E., Wesseling, Jelle, Rodenhuis, Sjoerd, Peeters, Marie-Jeanne T. F. D. Vrancken, Sikorska, Karolina, Gilhuijs, Kenneth G. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975876/
https://www.ncbi.nlm.nih.gov/pubmed/27495815
http://dx.doi.org/10.1186/s13058-016-0742-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975876/
https://www.ncbi.nlm.nih.gov/pubmed/27495815
http://dx.doi.org/10.1186/s13058-016-0742-0

Ejemplares similares